NCT00524771View on ClinicalTrials.gov

Transatlantic Active Surveillance on Cardiovascular Safety of NuvaRing (TASC)

CompletedOBSERVATIONAL
Enrollment

34,100

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

March 31, 2012

Study Completion Date

June 30, 2012

Conditions
Contraception
Trial Locations (1)

10115

Berlin Center for Epidemiology and Health Research, Berlin

Sponsors

Collaborators (1)

Organon
All Listed Sponsors
collaborator

Organon

INDUSTRY

lead

Center for Epidemiology and Health Research, Germany

OTHER

NCT00524771 - Transatlantic Active Surveillance on Cardiovascular Safety of NuvaRing (TASC) | Biotech Hunter | Biotech Hunter